arBtrage CAPITALIZING MARKETS checking… Sign in

Veru Inc.

VERU Health Care Biotechnology: Pharmaceutical Preparations
$3.40
▼ -19.6% Today
as of Jun 7, 07:30 ET
Last 30 days +48.47% Apr 28 → Jun 05
$1.92 $2.54 $3.16 $3.78 $4.40 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.22
High
$4.27
Low
$3.32
Volume
$11M
Avg Vol
$551,422
Mkt Cap
$37M
P/E (TTM)
Beta
52w High
$7.40
52w Low
$2.05
Div Yield
Shares Out
$16M

Overview

52-week range
$2.05
$7.40
25% of range
Avg surprise (last 2)
+40.8%
Avg reaction (last 2)
+1.8%
50% positive
Latest IV / EM
291%
EM ±27.2% · $4 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.37$-0.29$-0.21$-0.13$-0.05 Actual $-0.08Actual $-0.08Actual $-0.07Actual $-0.05Est $-0.06Actual $-0.13Est $-0.37 JunDecMarMar/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-11M$-9M$-7M$-5M$-3M Jun 24Dec 24Mar 25Jun 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.13 $-0.37 +64.9% -160.0% -0.4% earnings
Thu May 8, 2025Mar/2025 $-0.05 $-0.06 +16.7% +4.0% earnings
Sun Mar 31, 2024Mar 2024 $-0.07 financials
Sun Dec 31, 2023Dec 2023 $-0.08 financials
Fri Jun 30, 2023Jun 2023 $-0.08 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$3M
Gross profit$1M
Operating income$-7M$-5M$-8M$-8M$-10M$-11M
Net income$-3M$-5M$-7M$-8M$-9M$-11M
EPS (diluted)

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$28M$33M$16M$15M$20M$27M$25M$29M
Inventory$5M
Total current assets$33M$37M$19M$16M$21M$28M$35M$38M
Total assets$43M$48M$30M$27M$33M$40M$60M$65M
Long-term debt
Total liabilities$8M$10M$12M$12M$12M$13M$28M$27M
Total equity$35M$37M$18M$15M$21M$27M$32M$38M

Implied volatility — last 90 days

286%288%291%293%296% Jun 07 — IV 291% · EM ±27.2%

Sector peers